Summary:
- This article discusses a new nasal spray treatment called esketamine that has been shown to have rapid antidepressant effects when used as a standalone treatment for depression.
- Esketamine is a derivative of the anesthetic ketamine and works differently from traditional antidepressants by targeting the glutamate system in the brain rather than the serotonin system.
- The study found that esketamine nasal spray, when used in combination with a newly initiated oral antidepressant, led to a significant reduction in depressive symptoms within 24 hours, providing a potential new treatment option for individuals with treatment-resistant depression.